| Pharmaceutical active ingredients: |
| TrandolaprilVerapamil Hydrochloride |
| Available forms, composition and doses of Tarka: |
| Capsules, Prolonged Release; Oral; Trandolapril 2 mg; Verapamil Hydrochloride 180 mgTablets, Extended Release; Oral; Trandolapril 1 mg; Verapamil Hydrochloride 240 mgTablets, Extended Release; Oral; Trandolapril 2 mg; Verapamil Hydrochloride 180 mgTablets, Extended Release; Oral; Trandolapril 2 mg; Verapamil Hydrochloride 240 mgTablets, Extended Release; Oral; Trandolapril 4 mg; Verapamil Hydrochloride 240 mg |
| Tarka medical category: |
| Human:Angiotensin-converting enzyme inhibitorsCalcium-channel blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09BB10 - Trandolapril and verapamil |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AbbottKnollRoche |